D-0140-2024 Class III Terminated

Recalled by Right Value Drug Stores, LLC Dba Carie Boyd's Prescription Shop — Irving, TX

FDA drug recall D-0140-2024 was initiated by Right Value Drug Stores, LLC Dba Carie Boyd's Prescription Shop on Nov 9, 2023 and is designated Class III. Reason for recall: Product Mix-up: Incorrect Product Formulation The recall status is terminated (terminated Aug 20, 2024). Affected quantity: 190 syringes.

Recall details

Product Type
Drugs
Report Date
Dec 13, 2023
Initiation Date
Nov 9, 2023
Termination Date
Aug 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
190 syringes

Product description

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Reason for recall

Product Mix-up: Incorrect Product Formulation

Distribution pattern

USA Nationwide

Code information

Lot#: 09202023@7, Exp 03/18/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0140-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0140-2024. Report a data issue: hello@regdatalab.com.